Report cover image

Emcure Pharmaceuticals Ltd - Strategic SWOT Analysis Review

Publisher GlobalData
Published Oct 18, 2023
Length 27 Pages
SKU # GBDT18270981

Description

Emcure Pharmaceuticals Ltd - Strategic SWOT Analysis Review


- provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – GlobalData’s summarization of the company’s business strategy.
  • SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
Highlights

Emcure Pharmaceuticals Ltd (Emcure) develops, manufactures, and commercializes pharmaceutical products worldwide. The company develops and manufactures branded generic products. It also manufactures active pharmaceutical ingredients (APIs) primarily for use in the manufacturing of pharmaceutical products. Emcure has a presence in all major therapeutic areas, which comprises cardiology, pain and analgesics, HIV, gynecology, blood-related, anti-infective, nephrology, diabetes, and cancer among others as well as vitamins, minerals, and nutrients products. It has an operational presence in Brazil, Dubai, South Africa, Singapore, and Nigeria. The company has branch offices in Russia and Morocco. Emcure is headquartered in Pune, Maharashtra, India.

Emcure Pharmaceuticals Ltd Key Recent Developments

Mar 17,2022: 35 generic manufacturers sign agreements with MPP to produce low-cost, generic versions of Pfizer’s oral COVID-19 treatment nirmatrelvir in combination with ritonavir for supply in 95 low- and middle-income countries

Reasons to Buy
  • Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
  • Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
  • Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
  • Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.
Note:Some sections may be missing if data is unavailable for the company.

Table of Contents

27 Pages
Section 1 - About the Company
Emcure Pharmaceuticals Ltd - Key Facts
Emcure Pharmaceuticals Ltd - Key Employees
Emcure Pharmaceuticals Ltd - Key Employee Biographies
Emcure Pharmaceuticals Ltd - Major Products and Services
Emcure Pharmaceuticals Ltd - History
Emcure Pharmaceuticals Ltd - Company Statement
Emcure Pharmaceuticals Ltd - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Emcure Pharmaceuticals Ltd - Business Description
R&D Overview
Emcure Pharmaceuticals Ltd - Corporate Strategy
Emcure Pharmaceuticals Ltd - SWOT Analysis
SWOT Analysis - Overview
Emcure Pharmaceuticals Ltd - Strengths
Emcure Pharmaceuticals Ltd - Weaknesses
Emcure Pharmaceuticals Ltd - Opportunities
Emcure Pharmaceuticals Ltd - Threats
Emcure Pharmaceuticals Ltd - Key Competitors
Section 3 – Company’s Lifesciences Financial Deals and Alliances
Emcure Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023
Emcure Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2017 to YTD 2023
Emcure Pharmaceuticals Ltd, Recent Deals Summary
Section 4 – Company’s Recent Developments
Mar 17, 2022: 35 generic manufacturers sign agreements with MPP to produce low-cost, generic versions of Pfizer’s oral COVID-19 treatment nirmatrelvir in combination with ritonavir for supply in 95 low- and middle-income countries
Section 5 – Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List of Tables
Emcure Pharmaceuticals Ltd, Key Facts
Emcure Pharmaceuticals Ltd, Key Employees
Emcure Pharmaceuticals Ltd, Key Employee Biographies
Emcure Pharmaceuticals Ltd, Major Products and Services
Emcure Pharmaceuticals Ltd, History
Emcure Pharmaceuticals Ltd, Other Locations
Emcure Pharmaceuticals Ltd, Subsidiaries
Emcure Pharmaceuticals Ltd, Key Competitors
Emcure Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023
Emcure Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2017 to YTD 2023
Emcure Pharmaceuticals Ltd, Recent Deals Summary
List of Figures
Emcure Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023
Emcure Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2017 to YTD 2023

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us